Clinical Trials in Baltimore

Showing 4341-4360 of 23,476 trials

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

NCT03828994

The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) will receive additional testing and treatment in the field. The investigators hypothesize that repackaging the recommended Centers for Disease Control and Prevention (CDC) follow-up visit using a technology-enhanced community health nursing intervention (TECH-N) with integration of an evidence-based sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost-effective compared with outpatient standard of care (and hospitalization).

Pelvic Inflammatory Disease

Johns Hopkins University150 participantsStarted Feb 2019

Baltimore, Maryland, United States

TERMINATEDPhase 2/322 miles

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

NCT04417257

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.

COVID-19 Disease

Laurent Pharmaceuticals Inc.351 participantsStarted Aug 2020

Chandler, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +26 more locations

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

Find Trials by Condition in Baltimore

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

The PEERLESS Study

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study

Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults

STOP Persistent AF PAS

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

B-PaLMZ for TB Meningitis